Annual EBITDA
$613.04M$13.20M-2.11%
Summary
- Current Value
- As of today, BMRN annual EBITDA is $613.04M, down -2.11% on
- Historical Performance
- BMRN annual EBITDA is up +446.48% over the past 3 years, up +60596.53% over the past 5 years
- All-Time High Comparison
- BMRN annual EBITDA is currently -2.11% below its historical high of $626.23M set on
- 3-Year Low Comparison
- BMRN annual EBITDA is +446.48% above its 3-year low of $112.18M reached on an earlier date
- Sector Comparison
- BMRN annual EBITDA is higher than 91.27% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $613.04M | -2.1% | +446.5% | +10000.0% | +2297.8% | |
| Quarterly EBITDA | $302.06M | -5.6% | +267.5% | +547.2% | +3552.9% | |
| TTM EBITDA | $792.51M | -12.7% | +361.7% | +1164.7% | +2265.3% | |
| Price | $67.36 | +16.1% | -25.4% | -10.2% | +148.6% | |
| PE Ratio | 181.61 | +957.1% | +3.9% | +925.5% | +878.5% | |
| Annual Revenue | $3.24B | +14.2% | +58.3% | +76.0% | +772.5% | |
| Annual EPS | $1.80 | -18.2% | +140.9% | -60.1% | +10.0% | |
| $533.48M | +0.7% | +5125.1% | +608.7% | +10000.0% | ||
| Annual Net Income | $348.90M | -18.3% | +146.5% | -59.4% | +69.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $626.23M | -2.1% | |
| 5Y | $626.23M | -2.1% | |
| All | $626.23M | -2.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $112.18M | N/A | +446.5% |
| 5Y | $1.01M | N/A | >+9999.0% |
| All | -$276.31M | +321.9% |
EBITDA History
FAQ
- What is the current annual EBITDA of BMRN?
- As of today, BMRN annual EBITDA is $613.04M
- What is 1-year change in BMRN annual EBITDA?
- BMRN annual EBITDA is down -2.11% year-over-year
- What is 3-year change in BMRN annual EBITDA?
- BMRN annual EBITDA is up +446.48% over the past 3 years
- How far is BMRN annual EBITDA from its all-time high?
- BMRN annual EBITDA is currently -2.11% below its historical high of $626.23M set on December 31, 2024
- How does BMRN annual EBITDA rank versus sector peers?
- BMRN annual EBITDA is higher than 91.27% of companies in Healthcare sector
- When is BMRN next annual earnings release?
- As of today, the next annual earnings release for BMRN has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$302.06M$135.28M+81.12%
Summary
- Current Value
- As of today, BMRN quarterly EBITDA is $302.06M, up +81.12% on
- Historical Performance
- BMRN quarterly EBITDA is down -5.63% year-over-year, up +267.51% over the past 3 years
- All-Time High Comparison
- BMRN quarterly EBITDA is currently -5.63% below its historical high of $320.07M set on
- 3-Year Low Comparison
- BMRN quarterly EBITDA is +522.60% above its 3-year low of $48.52M reached on
- Sector Comparison
- BMRN quarterly EBITDA is higher than 93.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $302.06M | +81.1% | -5.6% | +267.5% | +547.2% | |
| Annual EBITDA | $613.04M | – | -2.1% | +446.5% | +10000.0% | |
| TTM EBITDA | $792.51M | -2.2% | -12.7% | +361.7% | +1164.7% | |
| Price | $67.36 | +26.5% | +16.1% | -25.4% | -10.2% | |
| PE Ratio | 181.61 | +367.5% | +957.1% | +3.9% | +925.5% | |
| Quarterly Revenue | $996.38M | +28.0% | +20.4% | +67.6% | +97.5% | |
| Quarterly EPS | $0.23 | -57.6% | -81.3% | -21.2% | +229.8% | |
| $204.42M | +36.0% | -32.2% | +260.1% | +950.6% | ||
| Quarterly Net Income | $44.76M | -57.6% | -81.4% | -20.1% | +245.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $320.07M | N/A | -5.6% |
| 3Y | $320.07M | -5.6% | |
| 5Y | $320.07M | -5.6% | |
| All | $320.07M | -5.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $120.28M | +151.1% | |
| 3Y | $48.52M | +522.6% | |
| 5Y | -$42.62M | +808.8% | |
| All | -$110.13M | +374.3% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of BMRN?
- As of today, BMRN quarterly EBITDA is $302.06M
- What is BMRN quarterly EBITDA most recent change?
- BMRN quarterly EBITDA was up +81.12% on June 30, 2026
- What is 1-year change in BMRN quarterly EBITDA?
- BMRN quarterly EBITDA is down -5.63% year-over-year
- How far is BMRN quarterly EBITDA from its all-time high?
- BMRN quarterly EBITDA is currently -5.63% below its historical high of $320.07M set on June 30, 2025
- How does BMRN quarterly EBITDA rank versus sector peers?
- BMRN quarterly EBITDA is higher than 93.05% of companies in Healthcare sector
- When is BMRN next earnings release?
- The next earnings release for BMRN is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$792.51M$18.01M-2.22%
Summary
- Current Value
- As of today, BMRN TTM EBITDA is $792.51M, down -2.22% on
- Historical Performance
- BMRN TTM EBITDA is down -12.70% year-over-year, up +361.68% over the past 3 years
- All-Time High Comparison
- BMRN TTM EBITDA is currently -15.53% below its historical high of $938.17M set on
- 3-Year Low Comparison
- BMRN TTM EBITDA is +361.68% above its 3-year low of $171.66M reached on an earlier date
- Sector Comparison
- BMRN TTM EBITDA is higher than 91.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $792.51M | -2.2% | -12.7% | +361.7% | +1164.7% | |
| Annual EBITDA | $613.04M | – | -2.1% | +446.5% | +10000.0% | |
| Quarterly EBITDA | $302.06M | +81.1% | -5.6% | +267.5% | +547.2% | |
| Price | $67.36 | +26.5% | +16.1% | -25.4% | -10.2% | |
| PE Ratio | 181.61 | +367.5% | +957.1% | +3.9% | +925.5% | |
| TTM Revenue | $3.46B | +5.1% | +13.7% | +57.6% | +80.2% | |
| TTM EPS | $0.37 | -72.9% | -89.0% | -28.2% | -91.2% | |
| $639.54M | -13.2% | -22.4% | +805.1% | +1388.6% | ||
| TTM Net Income | $72.97M | -72.8% | -88.9% | -27.0% | -91.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $938.17M | -15.5% | |
| 3Y | $938.17M | -15.5% | |
| 5Y | $938.17M | -15.5% | |
| All | $938.17M | -15.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $792.51M | at low | |
| 3Y | $171.66M | N/A | +361.7% |
| 5Y | $32.27M | +2355.8% | |
| All | -$287.89M | +375.3% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of BMRN?
- As of today, BMRN TTM EBITDA is $792.51M
- What is BMRN TTM EBITDA most recent change?
- BMRN TTM EBITDA was down -2.22% on June 30, 2026
- What is 1-year change in BMRN TTM EBITDA?
- BMRN TTM EBITDA is down -12.70% year-over-year
- How far is BMRN TTM EBITDA from its all-time high?
- BMRN TTM EBITDA is currently -15.53% below its historical high of $938.17M set on September 30, 2025
- How does BMRN TTM EBITDA rank versus sector peers?
- BMRN TTM EBITDA is higher than 91.63% of companies in Healthcare sector
- When is BMRN next earnings release?
- The next earnings release for BMRN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BMRN Official Website www.biomarin.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm
- BMRN Profile on Yahoo Finance finance.yahoo.com/quote/BMRN
- BMRN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bmrn